Nanosecond pulsed electric field ablation‐induced modulation of sphingolipid metabolism is associated with Ly6c2 + mononuclear phagocyte differentiation in liver cancer

Preclinical studies have proven that nanosecond pulsed electric field (nsPEF) ablation can be a safe and effective treatment for humans with unresectable liver cancer that are ineligible for thermal ablation. The concomitant activation of antitumor immunity by nsPEF can also potentially prevent tumor recurrence. However, whether nsPEF exhibits similar efficacy in a clinical setting remains to be investigated. A prospective clinical trial (clinicaltrials.gov identifier: NCT04039747) was conducted to evaluate the safety and efficacy of ultrasound (US)‐guided nsPEF ablation in 15 patients with unresectable liver cancer that were ineligible for thermal ablation. We found that nsPEF ablation was safe and produced a 12‐month recurrence‐free survival (RFS) and local RFS of 60% (9/15) and 86.7% (13/15), respectively, in the enrolled patients. Integrative proteomic and metabolomic analysis showed that sphingolipid metabolism was the most significantly enriched pathway in patient sera after nsPEF without recurrence within 8 months. A similar upregulation of sphingolipid metabolism was observed in the intratumoral mononuclear phagocytes (MNPs), rather than other immune and nonimmune cells, of an nsPEF‐treated mouse model. We then demonstrated that lymphocyte antigen 6 complex, locus C2‐positive (Ly6c2+) monocytes first differentiated into Ly6c2+ monocyte‐derived macrophages with an increase in sphingolipid metabolic activity, and subsequently into Ly6c2+ dendritic cells (DCs). Ly6c2+ DCs communicated with CD8+ T cells and increased the proportions of IFN‐γ+ CD8+ memory T cells after nsPEF, and this finding was subsequently confirmed by depletion of liver Ly6c2+ MNPs. In conclusion, nsPEF was a safe and effective treatment for liver cancer. The alteration of sphingolipid metabolism induced by nsPEF was associated with the differentiation of Ly6c2+ MNPs, and subsequently induced the formation of memory CD8+ T cells with potent antitumor effect.

[1]  Shu-sen Zheng,et al.  Ultrasound-guided in vivo porcine liver ablation with nanosecond pulsed electric fields. , 2022, Hepatobiliary & pancreatic diseases international : HBPD INT.

[2]  Qiyu Zhao,et al.  The Safety and Efficacy of Nanosecond Pulsed Electric Field in Patients With Hepatocellular Carcinoma: A Prospective Phase 1 Clinical Study Protocol , 2022, Frontiers in Oncology.

[3]  J. Borghans,et al.  Turnover of Murine Cytomegalovirus–Expanded CD8+ T Cells Is Similar to That of Memory Phenotype T Cells and Independent of the Magnitude of the Response , 2022, The Journal of Immunology.

[4]  Ioana M. Lemnian,et al.  Transcriptional Analysis of Total CD8+ T Cells and CD8+CD45RA- Memory T Cells From Young and Old Healthy Blood Donors , 2022, Frontiers in Immunology.

[5]  R. Mallik,et al.  Mapping Sphingolipid Metabolism Pathways during Phagosomal Maturation. , 2021, ACS chemical biology.

[6]  K. Severinov,et al.  Human short peptidoglycan recognition protein PGLYRP1/Tag‐7/PGRP‐S inhibits Listeria monocytogenes intracellular survival in macrophages , 2021, The FASEB Journal.

[7]  L. Joosten,et al.  Prosaposin mediates inflammation in atherosclerosis , 2021, Science Translational Medicine.

[8]  T. Jiang,et al.  Antitumor Effect and Immune Response of Nanosecond Pulsed Electric Fields in Pancreatic Cancer , 2021, Frontiers in Oncology.

[9]  Lanjuan Li,et al.  Mesenchymal stem cell-mediated immunomodulation of recruited mononuclear phagocytes during acute lung injury: a high-dimensional analysis study , 2021, Theranostics.

[10]  Ruibin Xi,et al.  Global immune characterization of HBV/HCV-related hepatocellular carcinoma identifies macrophage and T-cell subsets associated with disease progression , 2020, Cell Discovery.

[11]  M. Raaben,et al.  The SPPL3-Defined Glycosphingolipid Repertoire Orchestrates HLA Class I-Mediated Immune Responses. , 2020, Immunity.

[12]  Lanjuan Li,et al.  Mesenchymal stem cells alleviate LPS-induced acute lung injury by inhibiting the proinflammatory function of Ly6C+ CD8+ T cells , 2020, Cell Death & Disease.

[13]  Lanjuan Li,et al.  Immunosuppressive effects of mesenchymal stem cells on lung B cell gene expression in LPS-induced acute lung injury , 2020, Stem Cell Research & Therapy.

[14]  Haiyang Xie,et al.  Blocking exposed PD-L1 elicited by nanosecond pulsed electric field reverses dysfunction of CD8+ T cells in liver cancer. , 2020, Cancer letters.

[15]  Christian M. Metallo,et al.  Serine restriction alters sphingolipid diversity to constrain tumour growth , 2020, Nature.

[16]  Z. Tian,et al.  Impaired lipid biosynthesis hinders anti-tumor efficacy of intratumoral iNKT cells , 2020, Nature Communications.

[17]  Lanjuan Li,et al.  Immunomodulatory effect of mesenchymal stem cells in chemical-induced liver injury: a high-dimensional analysis , 2019, Stem Cell Research & Therapy.

[18]  Ali Rashidfarrokhi,et al.  Sphingomyelin Biosynthesis Is Essential for Phagocytic Signaling during Mycobacterium tuberculosis Host Cell Entry , 2019, mBio.

[19]  Jue Zhang,et al.  Nanosecond pulsed electric field inhibits malignant melanoma growth by inducing the change of systemic immunity , 2019, Medicina oral, patologia oral y cirugia bucal.

[20]  Tian Yang,et al.  Propensity score analyses of long-term outcomes of perivascular hepatocellular carcinoma: Radiofrequency ablation vs. surgery. , 2018, Hepatobiliary & pancreatic diseases international : HBPD INT.

[21]  D. Sinn,et al.  Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes. , 2018, Journal of hepatology.

[22]  S. Beebe,et al.  Nano-Pulse Stimulation Ablates Orthotopic Rat Hepatocellular Carcinoma and Induces Innate and Adaptive Memory Immune Mechanisms that Prevent Recurrence , 2018, Cancers.

[23]  R. Heller,et al.  Nano‐pulse stimulation induces potent immune responses, eradicating local breast cancer while reducing distant metastases , 2018, International journal of cancer.

[24]  D. Rockey,et al.  Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice , 2018, Gastroenterology.

[25]  P. Henson,et al.  Monocyte differentiation and antigen-presenting functions , 2017, Nature Reviews Immunology.

[26]  A. Bielawska,et al.  Ceramide activates lysosomal cathepsin B and cathepsin D to attenuate autophagy and induces ER stress to suppress myeloid-derived suppressor cells , 2016, Oncotarget.

[27]  C. Buechler,et al.  Ceramide and polyunsaturated phospholipids are strongly reduced in human hepatocellular carcinoma. , 2016, Biochimica et biophysica acta.

[28]  A. Bradley,et al.  C13orf31 (FAMIN) is a central regulator of immunometabolic function , 2016, Nature Immunology.

[29]  J. Bruix,et al.  Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma. , 2016, Gastroenterology.

[30]  Richard Nuccitelli,et al.  Nanoelectroablation of Murine Tumors Triggers a CD8-Dependent Inhibition of Secondary Tumor Growth , 2015, PloS one.

[31]  Y. Tabata,et al.  Controlled release of sphingosine-1-phosphate agonist with gelatin hydrogels for macrophage recruitment. , 2014, Acta biomaterialia.

[32]  H. Weiner,et al.  Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation , 2014, Nature Medicine.

[33]  Florent Ginhoux,et al.  Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny , 2014, Nature Reviews Immunology.

[34]  M. Colombo,et al.  Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma. , 2014, Journal of hepatology.

[35]  Haiyang Xie,et al.  Nanosecond pulsed electric field (nsPEF) treatment for hepatocellular carcinoma: a novel locoregional ablation decreasing lung metastasis. , 2014, Cancer letters.

[36]  Maxim N. Artyomov,et al.  TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation , 2014, Nature Immunology.

[37]  Richard Nuccitelli,et al.  First‐in‐human trial of nanoelectroablation therapy for basal cell carcinoma: proof of method , 2014, Experimental dermatology.

[38]  Dorothy D. Sears,et al.  Macrophage Glucose-6-Phosphate Dehydrogenase Stimulates Proinflammatory Responses with Oxidative Stress , 2013, Molecular and Cellular Biology.

[39]  Stephen J. Beebe,et al.  Induction of Cell Death Mechanisms and Apoptosis by Nanosecond Pulsed Electric Fields (nsPEFs) , 2013, Cells.

[40]  Yosuke Osawa,et al.  Liver acid sphingomyelinase inhibits growth of metastatic colon cancer. , 2013, The Journal of clinical investigation.

[41]  M. Breton,et al.  Microsecond and nanosecond electric pulses in cancer treatments , 2012, Bioelectromagnetics.

[42]  G. Schmitz,et al.  Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes , 2010, Proceedings of the National Academy of Sciences.

[43]  R. Proia,et al.  Sphingosine-1-Phosphate Induces an Antiinflammatory Phenotype in Macrophages , 2008, Circulation research.

[44]  O. Seror,et al.  [The impact of large vessel proximity on effectiveness of radiofrequency ablation of hepatocellular carcinoma: a controlled study]. , 2008, Journal de Radiologie.

[45]  B. Brüne,et al.  Tumor cell apoptosis polarizes macrophages role of sphingosine-1-phosphate. , 2007, Molecular biology of the cell.

[46]  James Sayre,et al.  Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. , 2003, Journal of vascular and interventional radiology : JVIR.

[47]  T. Arima,et al.  Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation , 2003, Cancer.

[48]  Xuetao Cao,et al.  A Pck1-directed glycogen metabolic program regulates formation and maintenance of memory CD8+ T cells , 2017, Nature Cell Biology.

[49]  E. Pivovarova,et al.  Lipid synthesis in macrophages during inflammation in vivo: effect of agonists of peroxisome proliferator activated receptors alpha and gamma and of retinoid X receptors. , 2008, Biochemistry. Biokhimiia.

[50]  G. Wang,et al.  Induction of the , 1996 .